LGALS3 and idiopathic pulmonary fibrosis: Here, we evaluated the effect of TD139, a selective inhibitor with a high affinity for the Galectin-3 carbohydrate recognition domain in phase 2 clinical trials for IPF and COVID-19 pneumonitis (20, 21), on spontaneous development of autoimmune diabetes in NOD mice.